ArticleScientific reports2026

Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study.

Maria Alice Esteves da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.